Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Trends and Innovations in Biosensors for COVID‐19 Mass Testing

4 May 2020

Abstract excerpt

Fast and widespread diagnosis is crucial to fighting against the outbreak of COVID-19. This work surveys the landscape of available and emerging biosensor technologies for COVID-19 testing. Molecular diagnostic assays based on quantitative reverse transcription polymerase chain reaction are used in most clinical laboratories. However, the COVID-19 pandemic has overwhelmed testing capacity and motivated the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced biosensing and bioanalysis techniques
Share to Biosensors and Analytical Detection
Share to SARS-CoV-2 detection and testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32367615
DOI: 10.1002/cbic.202000250

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Trends and Innovations in Biosensors for COVID‐19 Mass TestingPMID 32367615Read ↗

Recent advances in point of care testing for COVID-19 detectionSemantic proximity Read ↗

Current trends in COVID-19 diagnosis and its new variants in physiological fluids: Surface antigens, antibodies, nucleic acids, and RNA sequencingSemantic proximity Read ↗

Next-Generation Nucleic Acid-Based Diagnostics for Viral Pathogens: Lessons Learned from the SARS-CoV-2 PandemicSemantic proximity Read ↗

Multiplexed biosensor for point-of-care COVID-19 monitoring: CRISPR-powered unamplified RNA diagnostics and protein-based therapeutic drug managementSemantic proximity Read ↗

Molecular diagnostic assays for COVID-19: an overviewSemantic proximity Read ↗

Multiplexed biosensor for point-of-care COVID-19 monitoring: CRISPR-powered unamplified RNA diagnostics and protein-based therapeutic drug managementSemantic proximity Read ↗

Advances in Nucleic Acid Assays for Infectious Disease: The Role of Microfluidic TechnologySemantic proximity Read ↗

The Future of Point-of-Care Nucleic Acid Amplification Diagnostics after COVID-19: Time to Walk the WalkSemantic proximity Read ↗

CRISPR-based biosensing systems: a way to rapidly diagnose COVID-19Semantic proximity Read ↗

Rapid, point-of-care molecular diagnostics with Cas13Semantic proximity Read ↗

Current Trends of SARS-CoV-2 and its New Variants Diagnostics in Different Body Fluids: Surface Antigen, Antibody, Nucleic Acid, and RNA Sequencing Detection TechniquesSemantic proximity Read ↗

Optimizing testing regimes for the detection of COVID-19 in children and older adults.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.